IGF-1 DES Guide: Dosage, Reconstitution & Localized Muscle Growth Explained

IGF-1 DES

IGF-1 DES (Des(1-3) IGF-1) is a shortened, highly active form of IGF-1 designed for rapid, localized effects. It is studied for muscle growth, tissue repair, and site-specific anabolic activity.

How It Works

Local IGF-1 Activity ↑ → Muscle Cell Activation ↑ → Growth Signaling ↑ → Targeted Tissue Repair

IGF-1 DES has a much shorter half-life than IGF-1 LR3, allowing it to act quickly at the injection site. It binds strongly to IGF receptors and is often studied for localized muscle growth and repair.

Important Distinction

IGF-1 DES is a short-acting version of IGF-1.

It is designed for localized effects rather than systemic circulation.

This makes it fundamentally different from IGF-1 LR3, which is long-acting.

IGF-1 DES Protocol

1 mg vial + 1.0 mL BAC Water → 1 unit = 10 mcg → Short-Acting Localized IGF-1 Support

Standard / Targeted Approach

1 mg vial reconstituted with 1.0 mL bacteriostatic water

1 unit = 10 mcg

Per Injection

Standard Range

Dose20–50 mcg

Units2–5 units

TimingImmediately post-workout most common

Advanced

Higher Range

Dose50–100 mcg

Units5–10 units

Use ContextAdvanced / targeted research use

Simple structure:

IGF-1 DES is typically discussed as a short-acting, localized compound. Timing and injection placement matter more than with longer-acting IGF-1 variants because the activity window is brief.

How to Use IGF-1 DES (Cycle, Timing & Injection)

Frequency1–2 injections per day

TimingImmediately post-workout most common

RouteIntramuscular localized or subcutaneous

Cycle Length2–4 weeks

Primary UseTargeted local growth / tissue repair signaling

Best Time to Use

Immediately post-workout is the most commonly discussed timing.

Because IGF-1 DES is short-acting, timing is usually more important than with longer-acting IGF-1 LR3.

Some advanced protocols discuss 1–2 injections per day, depending on goal and tolerance.

Where to Inject

Inject directly into the target muscle when localized IM use is the goal.

Localized injection is key for the intended site-specific effect.

Subcutaneous use is also discussed, but it is less targeted than localized IM use.

Rotate injection sites regularly to reduce irritation.

When to Use

During targeted muscle-growth phases

During localized tissue-repair phases

When site-specific anabolic signaling is the research focus

As a short cycle rather than a long continuous protocol

Simple Strategy

Use in Short Phases

IGF-1 DES is best framed as a short, targeted phase because of its rapid activity and localized intent.

Goal-Based Use

Use it when the goal is localized repair or site-specific muscle signaling, then reassess after the short support block.

Real-World vs Clinical Use

Real-World Use

Typical Dose20–50 mcg per site

GoalLocalized muscle growth

Clinical / Research Context

FocusTissue repair + growth signaling

RealityVery short half-life, about 20–30 minutes

Reconstitution & Dosing

Reconstitution & Dosing

Vial1 mg

Water1.0 mL

Concentration1,000 mcg/mL

Conversion1 unit = 10 mcg

Dose Reference

2 units = 20 mcg

3 units = 30 mcg

5 units = 50 mcg

10 units = 100 mcg

Reconstitution Steps

Draw 1.0 mL bacteriostatic water

Inject slowly into vial or down the vial wall

Gently swirl, do not shake

Allow powder to fully dissolve before use

Refrigerate after reconstitution

Important:

Unit math depends on vial size and water volume. This example uses a 1 mg vial with 1.0 mL added, creating a clean 1 unit = 10 mcg conversion.

Storage & Shelf Life

Storage & Shelf Life

Lyophilized (unmixed)

Refrigerated (2–8°C): ~12–24 months

Frozen (−20°C): up to ~2–3 years

Store sealed, dry, and protected from light

Reconstituted (mixed)

Refrigerated (2–8°C): about 2–3 weeks typical use window

Do not freeze after mixing

Avoid repeated temperature changes

Best Practice

Handling

Keep the vial cold, protected from light, and limit unnecessary handling.

Visual Check

If the solution becomes cloudy, discolored, or contains visible particles, it is safer not to continue using it.

Time Between Cycles

Short Targeted Phase → Reset → Reassess → Repeat if Needed

Standard Time Between Cycles

Cycle Length2–4 weeks

Time Off2–4 weeks

Why take a break?

IGF-1 DES is usually discussed in short, targeted phases because it is a powerful growth-signaling compound with a rapid activity window. Time off helps reassess response, injection tolerance, and blood sugar effects before repeating.

Best Ways to Structure It

Option 12–4 weeks on, 2–4 weeks off

Best simple structure for short targeted use

Option 2Use only during a targeted training block

Then stop once the focused growth or repair phase ends

Option 3Short trial phase

Useful for assessing localized response before extending use

When to Stop Sooner

Blood sugar symptoms become noticeable

Dizziness, headache, or discomfort increases

Injection site irritation becomes persistent

You are continuing without a clear targeted goal

Monitoring During Use

Muscle fullness at injection site

Recovery speed

Blood sugar response

Injection tolerance

Benefits

Supports localized muscle growth

Enhances recovery

Promotes tissue repair

Rapid onset of action

Potential Side Effects

Low blood sugar, also called hypoglycemia

Injection site irritation

Dizziness

Headache

Important Notes

Short-acting compared to IGF-1 LR3

Often used for targeted effects

Requires precise timing

Blood sugar awareness is important

Localized injection is central to the intended research use

Important Disclaimer

IGF-1 DES is an investigational compound and is not FDA-approved. This content is for educational purposes only.

IGF-1 DES Guide → Browse All Peptides →